Opportunity Information: Apply for RFA HL 09 005
Apply for RFA HL 09 005
- The National Institutes of Health in the health sector is offering a public funding opportunity titled "NHLBI Progenitor Cell Biology Consortium Administrative Coordinating Center (U01)" and is now available to receive applicants.
- Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.837 Cardiovascular Diseases Research 93.839 Blood Diseases and Resources Research.
- This funding opportunity was created on Jan 30, 2009 and posted on Jan 30, 2009.
- Applicants must submit their applications by May 1, 2009. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
- Each selected applicant is eligible to receive up to $600,000.00 in funding.
- Eligible applicants include: Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education Others (see text field entitled Additional Information on Eligibility for clarification) Private institutions of higher education Small businesses For profit organizations other than small businesses Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education Public and State controlled institutions of higher education State governments.
- Other Eligible Applicants include the following Alaska Native and Native Hawaiian Serving Institutions Eligible Agencies of the Federal Government Hispanic serving Institutions Historically Black Colleges and Universities (HBCUs) Tribally Controlled Colleges and Universities (TCCUs) .
[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal:
Opportunity Summary:
This grant opportunity (RFA-HL-09-005) is a National Institutes of Health (NIH), National Heart, Lung, and Blood Institute (NHLBI) funding announcement seeking an organization to serve as the Administrative Coordinating Center (ACC) for the NHLBI Progenitor Cell Biology Consortium. The Consortium itself is built around a set of NHLBI-supported Research Hubs (referenced in a companion announcement, RFA-HL-09-004) that function as "virtual" hubs: clusters of coordinated, synergistic research projects carried out by multidisciplinary teams of principal investigators. The ACC is meant to be the central organizational and operational backbone that helps those distributed Research Hubs function as one integrated program rather than as disconnected projects.
At a program level, the Consortium is focused on major frontiers in progenitor and stem cell biology that are directly relevant to heart, lung, and blood research. Its scientific goals include identifying and characterizing progenitor cell lineages, learning how to control or direct the differentiation of stem and progenitor cells toward specific desired cell fates, and developing strategies to overcome practical and biological hurdles related to transplanting these cells. The emphasis is not only on basic lineage and differentiation biology, but also on translational challenges that arise when moving progenitor-cell-based approaches closer to therapeutic use, particularly issues unique to cell transplantation. In addition to the research projects themselves, the Consortium is described as including core research support facilities and skills development components, implying shared resources and workforce development activities that the ACC would help coordinate across sites.
The funding mechanism is a Cooperative Agreement under the U01 activity code, which generally indicates that NHLBI expects substantial programmatic involvement during the period of performance compared with a standard research project grant. In practical terms, the ACC role is typically expected to coordinate consortium-wide administration, communications, meetings, reporting, and other cross-cutting functions that enable collaboration and consistency across multiple participating research teams and cores. While the summary text does not enumerate specific ACC tasks in detail, the nature of an ACC for a multi-site consortium commonly includes managing schedules and deliverables, facilitating data and material sharing processes, supporting governance structures (committees, working groups), organizing consortium meetings and teleconferences, maintaining shared documentation, and ensuring timely interaction with NHLBI program staff consistent with the cooperative agreement model.
The opportunity is categorized as discretionary funding and lists Health as the primary activity area. It is associated with CFDA numbers 93.837 (Cardiovascular Diseases Research) and 93.839 (Blood Diseases and Resources Research), reflecting NHLBI mission areas connected to the Consortium's stem/progenitor cell emphasis. The announcement indicates no cost-sharing or matching requirement. The award ceiling is listed as $600,000, setting an upper limit on the amount available per award under this solicitation (as presented in the provided source data).
Eligibility is broad and includes a range of domestic organizational types, spanning nonprofit and for-profit entities and academic institutions. Specifically included are nonprofits with and without 501(c)(3) status (other than institutions of higher education), private institutions of higher education, public and state-controlled institutions of higher education, small businesses, and for-profit organizations other than small businesses, as well as state governments. Additional eligible applicants explicitly include Alaska Native and Native Hawaiian Serving Institutions, eligible agencies of the federal government, Hispanic-serving institutions, Historically Black Colleges and Universities (HBCUs), and Tribally Controlled Colleges and Universities (TCCUs). This breadth suggests NHLBI was open to receiving applications from institutions with strong administrative, coordinating, and scientific-program support capacity, not only traditional academic coordinating centers.
Key dates show the announcement was posted and created on January 30, 2009, with an original and current closing date of May 1, 2009, and an archive date of June 1, 2009. The listed agency is NIH, with NHLBI as the institute issuing the call. The primary reference link for the full funding announcement is provided (RFA-HL-09-005), and the notice includes contact guidance directing applicants having technical difficulty accessing the announcement to the NIH Office of Extramural Research (OER) webmaster email.
Frequently Asked Questions (FAQs)
What is this grant opportunity?
This opportunity (RFA-HL-09-005) is a National Institutes of Health (NIH), National Heart, Lung, and Blood Institute (NHLBI) funding announcement seeking an organization to serve as the Administrative Coordinating Center (ACC) for the NHLBI Progenitor Cell Biology Consortium.
Which NIH institute is offering this funding announcement?
The funding announcement is issued by NIH, specifically the National Heart, Lung, and Blood Institute (NHLBI).
What does ACC stand for in this announcement?
ACC stands for Administrative Coordinating Center.
What is the purpose of the Administrative Coordinating Center (ACC)?
The ACC is intended to be the central organizational and operational backbone for the NHLBI Progenitor Cell Biology Consortium, helping the distributed Research Hubs function as one integrated program rather than as disconnected projects.
What is the NHLBI Progenitor Cell Biology Consortium?
The Consortium is built around NHLBI-supported Research Hubs (referenced in a companion announcement, RFA-HL-09-004). These hubs function as "virtual" hubs: clusters of coordinated, synergistic research projects carried out by multidisciplinary teams of principal investigators.
How is the Consortium structured?
The Consortium is organized around multiple distributed, multidisciplinary Research Hubs that operate as "virtual" hubs, plus consortium-wide components such as core research support facilities and skills development elements. The ACC supports coordination across these parts.
Is there a related or companion funding announcement?
Yes. The Research Hubs are referenced as being supported under a companion announcement: RFA-HL-09-004.
What are the main scientific focus areas of the Consortium?
The Consortium focuses on major frontiers in progenitor and stem cell biology directly relevant to heart, lung, and blood research.
What scientific goals are described for the Consortium?
The stated goals include: identifying and characterizing progenitor cell lineages; learning how to control or direct the differentiation of stem and progenitor cells toward desired cell fates; and developing strategies to overcome practical and biological hurdles related to transplanting these cells.
Does the Consortium emphasize translational challenges as well as basic science?
Yes. In addition to basic lineage and differentiation biology, the Consortium emphasizes translational challenges involved in moving progenitor-cell-based approaches closer to therapeutic use, particularly issues unique to cell transplantation.
Are shared resources or workforce development activities included in the Consortium?
Yes. The Consortium is described as including core research support facilities and skills development components, implying shared resources and workforce development activities that the ACC would help coordinate across sites.
What funding mechanism is used for this opportunity?
The funding mechanism is a Cooperative Agreement under the U01 activity code.
What does it mean that this is a Cooperative Agreement (U01)?
Based on the announcement description, a U01 Cooperative Agreement generally indicates NHLBI expects substantial programmatic involvement during the period of performance compared with a standard research project grant.
What kinds of responsibilities are typically associated with the ACC role in a multi-site consortium?
While the summary does not list ACC tasks in exhaustive detail, it describes the ACC as providing central coordination and backbone functions. Common ACC functions for a multi-site consortium include coordinating consortium-wide administration, communications, meetings, reporting, schedules and deliverables; facilitating data and material sharing processes; supporting governance structures (committees and working groups); organizing meetings and teleconferences; maintaining shared documentation; and ensuring timely interaction with NHLBI program staff consistent with the cooperative agreement model.
What is the primary activity area for this opportunity?
The primary activity area listed is Health.
How is the opportunity categorized in terms of funding type?
It is categorized as discretionary funding.
What CFDA numbers are associated with this announcement?
The opportunity is associated with CFDA numbers 93.837 (Cardiovascular Diseases Research) and 93.839 (Blood Diseases and Resources Research).
What is the award ceiling for this solicitation?
The award ceiling is listed as $600,000, which sets an upper limit on the amount available per award under this solicitation (as presented in the provided source data).
Is cost sharing or matching required?
No. The announcement indicates there is no cost-sharing or matching requirement.
Who is eligible to apply?
Eligibility is broad and includes a range of domestic organizational types, including nonprofit and for-profit entities and academic institutions. Specifically included are: nonprofits with and without 501(c)(3) status (other than institutions of higher education); private institutions of higher education; public and state-controlled institutions of higher education; small businesses; for-profit organizations other than small businesses; and state governments.
Are any additional institution types explicitly listed as eligible?
Yes. Additional eligible applicants explicitly include: Alaska Native and Native Hawaiian Serving Institutions; eligible agencies of the federal government; Hispanic-serving institutions; Historically Black Colleges and Universities (HBCUs); and Tribally Controlled Colleges and Universities (TCCUs).
Does eligibility appear limited to traditional academic coordinating centers?
No. The breadth of eligible applicant types suggests NHLBI was open to applications from institutions with strong administrative, coordinating, and scientific-program support capacity, not only traditional academic coordinating centers.
What are the key dates for this announcement?
The announcement was posted and created on January 30, 2009. The original and current closing date is May 1, 2009. The archive date is June 1, 2009.
Where can applicants find the full funding announcement reference?
The primary reference link is identified as RFA-HL-09-005 (the full funding announcement).
Where can applicants get help if they have technical difficulty accessing the announcement?
The notice directs applicants with technical difficulty accessing the announcement to contact the NIH Office of Extramural Research (OER) webmaster email.
Browse more opportunities from the same category: Health
Next opportunity: Biomass Research and Development Initiative
Previous opportunity: NHLBI Progenitor Cell Biology Consortium Research Hubs (U01)
USGrants.org Applicant Portal:
Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.
Apply for RFA HL 09 005
[Watch] how do funding administrators access proposals?
Applicants also applied for:
Applicants who have applied for this opportunity (RFA HL 09 005) also looked into and applied for these:
| Funding Opportunity |
|---|
| Strengthening National Capacity in Malaria and Other Infectious Disease Operations Research (U01) Apply for RFA CK 09 004 Funding Number: RFA CK 09 004 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: $650,000 |
| Translational Tools for Clinical Studies of CAM Interventions (R01) Apply for RFA AT 09 002 Funding Number: RFA AT 09 002 Agency: National Institutes of Health Category: Health Funding Amount: $300,000 |
| Addressing Emerging Infectious Diseases in Bangladesh (U01) Apply for RFA CI 09 002 Funding Number: RFA CI 09 002 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: $2,000,000 |
| Poison Control Program Guidelines for the Management of Poisonings Cooperative Agreement Apply for HRSA 09 208 Funding Number: HRSA 09 208 Agency: Health Resources and Services Administration Category: Health Funding Amount: Case Dependent |
| Rural Health Best Practices and Community Development Cooperative Agreement Apply for HRSA 09 150 Funding Number: HRSA 09 150 Agency: Health Resources and Services Administration Category: Health Funding Amount: Case Dependent |
| Rural Research to Diverse Audiences Apply for HRSA 09 168 Funding Number: HRSA 09 168 Agency: Health Resources and Services Administration Category: Health Funding Amount: Case Dependent |
| Healthy Start Leadership Training Institute Apply for HRSA 09 165 Funding Number: HRSA 09 165 Agency: Health Resources and Services Administration Category: Health Funding Amount: $350,000 |
| Vision Screening for Young Children Coordinating Center Apply for HRSA 09 171 Funding Number: HRSA 09 171 Agency: Health Resources and Services Administration Category: Health Funding Amount: $300,000 |
| State MCH Early Childhood Comprehensive System Implementation Grants Apply for HRSA 09 176 Funding Number: HRSA 09 176 Agency: Health Resources and Services Administration Category: Health Funding Amount: $140,000 |
| High Impact Health Information Technology Apply for HRSA 09 199 Funding Number: HRSA 09 199 Agency: Health Resources and Services Administration Category: Health Funding Amount: Case Dependent |
| Radiological/Nuclear Medical Countermeasure Product Development Program (SBIRR43/R44) Apply for PA 09 093 Funding Number: PA 09 093 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Integrating Colorectal Cancer Screening within Chronic Disease Programs Apply for CDC RFA DP09 903 Funding Number: CDC RFA DP09 903 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: Case Dependent |
| Cooperative Agreements for State Based Public Health Laboratory Biomonitoring Programs Apply for CDC RFA EH09 902 Funding Number: CDC RFA EH09 902 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: $3,000,000 |
| Suicide Prevention in Emergency Medicine Departments (U01) Apply for RFA MH 09 150 Funding Number: RFA MH 09 150 Agency: National Institutes of Health Category: Health Funding Amount: $2,000,000 |
| Planning Grant Apply for HRSA 09 188 Funding Number: HRSA 09 188 Agency: Health Resources and Services Administration Category: Health Funding Amount: Case Dependent |
| Interventions for Youth and Young Adults with Fetal Alcohol Spectrum Disorders (U84) Apply for RFA DD 09 006 Funding Number: RFA DD 09 006 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: $350,000 |
| Impact of Tic Disorders, including Tourette Syndrome, in Youth, on Individuals, Families and Communities (U01) Apply for RFA DD 09 004 Funding Number: RFA DD 09 004 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: $400,000 |
| Prevention of Health Risk Behaviors among Youth with Attention Deficit/Hyperactivity Disorder Apply for RFA DD 09 003 Funding Number: RFA DD 09 003 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: $400,000 |
| Centers of Excellence in Public Health Informatics (P01) Apply for RFA HK 09 001 Funding Number: RFA HK 09 001 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: $1,000,000 |
| Rapid Scale Up of HIV Care and Treatment Services in the Republic of Cote dIvoire under PEPFAR Apply for CDC RFA PS09 910 Funding Number: CDC RFA PS09 910 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: $3,500,000 |
Grant application guides and resources
It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!
Apply for Grants
Premium leads for funding administrators, grant writers, and loan issuers
Thousands of people visit our website for their funding needs every day. When a user creates a grant proposal and files for submission, we pass the information on to funding administrators, grant writers, and government loan issuers.
If you manage government grant programs, provide grant writing services, or issue personal or government loans, we can help you reach your audience.
Subscribe to Leads
Request more information:
Would you like to learn more about this funding opportunity, similar opportunities to "RFA HL 09 005", eligibility, application service, and/or application tips? Submit an inquiry below:
Don't forget to subscribe to our grant alerts mailing list to receive weekly alerts on new and updated grant funding opportunities like this one in your email.